All sterile drug products from NuVision Pharmacy absence sterility assurance, FDA warns FDA expands aware of health care providers about insufficient sterility assurance of most sterile drug items from NuVision Pharmacy The U.S. Meals and Drug Administration is alerting healthcare providers of concerns in regards to a insufficient sterility assurance of all sterile drug items made and distributed by NuVision Pharmacy of Dallas, Texas. The FDA recommends these products shouldn’t be administered to patients.Multiphase computed tomography or dynamic contrast-enhanced magnetic resonance imaging of the chest, abdomen, and pelvis was performed during screening to determine the baseline disease-progression position twice. Results of the second imaging test, that was performed 12 to 24 weeks after the first imaging check, were regarded as the baseline results and were utilized to determine target-lesion sizes. Randomization was performed within the next four weeks. The screening period was shortened if scanning have been performed a few times in the last 24 weeks.